- call +1-201-465-4211
- email sales@mrinsights.biz
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
Scope of the Report:
North America ranks the top in terms of global market size of Antibody Drug Conjugate, it consists of 59.12% of the international market in 2016. Europe comes the second, with 27.70% of the global market. Asia Pacific consists of 6.54%of the Antibody Drug Conjugate market in the same year.
Takeda ranks the first in terms of revenue share in Global market of Antibody Drug Conjugate, occupies 54.17% of market share in 2016; While, Roche, with a market share of 35.11%, comes the second; The other companies consist of approximately 10.72% of the global market in 2016.
The worldwide market for Antibody-drug Conjugates is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Antibody-drug Conjugates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
ImmunoGen
Seattle Genetics
Roche
Takeda
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Adcetris
Kadcyla
Market Segment by Applications, can be divided into
Breast Cancer
Lymphoma
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody-drug Conjugates product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody-drug Conjugates, with price, sales, revenue and global market share of Antibody-drug Conjugates in 2017 and 2018.
Chapter 3, the Antibody-drug Conjugates competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody-drug Conjugates breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Antibody-drug Conjugates market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Antibody-drug Conjugates sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Antibody-drug Conjugates Introduction
1.2 Market Analysis by Type
1.2.1 Adcetris
1.2.2 Kadcyla
1.3 Market Analysis by Applications
1.3.1 Breast Cancer
1.3.2 Lymphoma
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 ImmunoGen
2.1.1 Business Overview
2.1.2 Antibody-drug Conjugates Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Seattle Genetics
2.2.1 Business Overview
2.2.2 Antibody-drug Conjugates Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Roche
2.3.1 Business Overview
2.3.2 Antibody-drug Conjugates Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Antibody-drug Conjugates Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Takeda Antibody-drug Conjugates Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Antibody-drug Conjugates Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Antibody-drug Conjugates Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Antibody-drug Conjugates Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibody-drug Conjugates Manufacturer Market Share in 2018
3.3.2 Top 6 Antibody-drug Conjugates Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Antibody-drug Conjugates Market Analysis by Regions
4.1 Global Antibody-drug Conjugates Sales, Revenue and Market Share by Regions
4.1.1 Global Antibody-drug Conjugates Sales and Market Share by Regions (2014-2019)
4.1.2 Global Antibody-drug Conjugates Revenue and Market Share by Regions (2014-2019)
4.2 North America Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
4.3 Europe Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
4.5 South America Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
5 North America Antibody-drug Conjugates by Country
5.1 North America Antibody-drug Conjugates Sales, Revenue and Market Share by Country
5.1.1 North America Antibody-drug Conjugates Sales and Market Share by Country (2014-2019)
5.1.2 North America Antibody-drug Conjugates Revenue and Market Share by Country (2014-2019)
5.2 United States Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
5.3 Canada Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
5.4 Mexico Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
6 Europe Antibody-drug Conjugates by Country
6.1 Europe Antibody-drug Conjugates Sales, Revenue and Market Share by Country
6.1.1 Europe Antibody-drug Conjugates Sales and Market Share by Country (2014-2019)
6.1.2 Europe Antibody-drug Conjugates Revenue and Market Share by Country (2014-2019)
6.2 Germany Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
6.3 UK Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
6.4 France Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
6.5 Russia Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
6.6 Italy Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
7 Asia-Pacific Antibody-drug Conjugates by Country
7.1 Asia-Pacific Antibody-drug Conjugates Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Antibody-drug Conjugates Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Antibody-drug Conjugates Revenue and Market Share by Country (2014-2019)
7.2 China Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
7.3 Japan Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
7.4 Korea Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
7.5 India Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
8 South America Antibody-drug Conjugates by Country
8.1 South America Antibody-drug Conjugates Sales, Revenue and Market Share by Country
8.1.1 South America Antibody-drug Conjugates Sales and Market Share by Country (2014-2019)
8.1.2 South America Antibody-drug Conjugates Revenue and Market Share by Country (2014-2019)
8.2 Brazil Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
8.3 Argentina Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
8.4 Colombia Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
9 Middle East and Africa Antibody-drug Conjugates by Countries
9.1 Middle East and Africa Antibody-drug Conjugates Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Antibody-drug Conjugates Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Antibody-drug Conjugates Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
9.3 Turkey Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
9.4 Egypt Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
9.5 Nigeria Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
9.6 South Africa Antibody-drug Conjugates Sales and Growth Rate (2014-2019)
10 Global Antibody-drug Conjugates Market Segment by Type
10.1 Global Antibody-drug Conjugates Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Antibody-drug Conjugates Sales and Market Share by Type (2014-2019)
10.1.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2014-2019)
10.2 Adcetris Sales Growth and Price
10.2.1 Global Adcetris Sales Growth (2014-2019)
10.2.2 Global Adcetris Price (2014-2019)
10.3 Kadcyla Sales Growth and Price
10.3.1 Global Kadcyla Sales Growth (2014-2019)
10.3.2 Global Kadcyla Price (2014-2019)
11 Global Antibody-drug Conjugates Market Segment by Application
11.1 Global Antibody-drug Conjugates Sales Market Share by Application (2014-2019)
11.2 Breast Cancer Sales Growth (2014-2019)
11.3 Lymphoma Sales Growth (2014-2019)
12 Antibody-drug Conjugates Market Forecast (2019-2024)
12.1 Global Antibody-drug Conjugates Sales, Revenue and Growth Rate (2019-2024)
12.2 Antibody-drug Conjugates Market Forecast by Regions (2019-2024)
12.2.1 North America Antibody-drug Conjugates Market Forecast (2019-2024)
12.2.2 Europe Antibody-drug Conjugates Market Forecast (2019-2024)
12.2.3 Asia-Pacific Antibody-drug Conjugates Market Forecast (2019-2024)
12.2.4 South America Antibody-drug Conjugates Market Forecast (2019-2024)
12.2.5 Middle East and Africa Antibody-drug Conjugates Market Forecast (2019-2024)
12.3 Antibody-drug Conjugates Market Forecast by Type (2019-2024)
12.3.1 Global Antibody-drug Conjugates Sales Forecast by Type (2019-2024)
12.3.2 Global Antibody-drug Conjugates Market Share Forecast by Type (2019-2024)
12.4 Antibody-drug Conjugates Market Forecast by Application (2019-2024)
12.4.1 Global Antibody-drug Conjugates Sales Forecast by Application (2019-2024)
12.4.2 Global Antibody-drug Conjugates Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Antibody-drug Conjugates Picture
Table Product Specifications of Antibody-drug Conjugates
Figure Global Sales Market Share of Antibody-drug Conjugates by Types in 20
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
